计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab175886-100μg |
100μg |
现货 ![]() |
| |
| Ab175886-1mg |
1mg |
现货 ![]() |
| |
| Ab175886-5mg |
5mg |
现货 ![]() |
| |
| Ab175886-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | Indusatumab (anti-GUCY2C) |
|---|---|
| 别名 | 英度妥单抗 |
| 英文别名 | GC-C antibody | Guanylyl cyclase C antibody | GUC2C antibody | GUC2C_HUMAN antibody | GUCY2C antibody | Heat stable enterotoxin receptor antibody | Heat-stable enterotoxin receptor antibody | hSTAR antibody | Intestinal guanylate cyclase antibody | STA re |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | GUCY2C |
| 种属反应性 | 人(Human),大鼠(Rat),猪(Pig),食蟹猴(Cynomolgus monkey) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 26.8 kDa (Light Chain) & 50.6 kDa (Heavy Chain), under reducing conditions; 179.3 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1497400-26-6 |
| 分子类型 | 抗体 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
Indusatumab (anti-GUCY2C) (Ab175886) - SEC
The purity of Indusatumab (anti-GUCY2C) (Ab175886) is more than 95% verified by HPLC.
Indusatumab (anti-GUCY2C) (Ab175886) - ELISA
Immobilized Hu-GUCY2C-his at 2.0 μg/mL can bind Indusatumab (anti-GUCY2C) (Ab175886) with the EC₅₀ of 8.18 ng/mL.
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | Ab175886 | |
| 分析证书 | Ab175886 | |
| 分析证书 | Ab175886 | |
| 分析证书 | Ab175886 | |
| 分析证书 | Ab175886 |
| 1. Harris LA, Crowell MD. (2007) Linaclotide, a new direction in the treatment of irritable bowel syndrome and chronic constipation.. Curr Opin Mol Ther, 9 (4): (403-10). [PMID:17694454] |
| 2. Busby RW, Bryant AP, Bartolini WP, Cordero EA, Hannig G, Kessler MM, Mahajan-Miklos S, Pierce CM, Solinga RM, Sun LJ et al.. (2010) Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.. Eur J Pharmacol, 649 (1-3): (328-35). [PMID:20863829] |
| 3. Shailubhai K, Palejwala V, Arjunan KP, Saykhedkar S, Nefsky B, Foss JA, Comiskey S, Jacob GS, Plevy SE. (2015) Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis.. World J Gastrointest Pharmacol Ther, 6 (4): (213-22). [PMID:26558155] |
| 4. de Sauvage, F J FJ, Camerato, T R TR and Goeddel, D V DV.. (1991) Primary structure and functional expression of the human receptor for Escherichia coli heat-stable enterotoxin.. The Journal of biological chemistry, (25): [PMID:1680854] |
| 5. Singh, S S, Singh, G G, Heim, J M JM and Gerzer, R R.. (1991) Isolation and expression of a guanylate cyclase-coupled heat stable enterotoxin receptor cDNA from a human colonic cell line.. Biochemical and biophysical research communications, (30): [PMID:1718270] |
| 6. Mann, E A EA, Cohen, M B MB and Giannella, R A RA.. (1993) Comparison of receptors for Escherichia coli heat-stable enterotoxin: novel receptor present in IEC-6 cells.. The American journal of physiology, [PMID:8381596] |
| 7. Mann, E A EA, Jump, M L ML and Glenella, R A RA.. (1996) Cell line-specific transcriptional activation of the promoter of the human guanylyl cyclase C/heat-stable enterotoxin/receptor gene.. Biochimica et biophysica acta, (7): [PMID:8605253] |
| 8. Scott, Robert O RO, Thelin, William R WR and Milgram, Sharon L SL.. (2002) A novel PDZ protein regulates the activity of guanylyl cyclase C, the heat-stable enterotoxin receptor.. The Journal of biological chemistry, (21): [PMID:11950846] |
| 9. Scherer, Steven E SE and 216 more authors.. (2006) The finished DNA sequence of human chromosome 12.. Nature, (16): [PMID:16541075] |
| 10. Fiskerstrand, Torunn T and 15 more authors.. (2012) Familial diarrhea syndrome caused by an activating GUCY2C mutation.. The New England journal of medicine, (26): [PMID:22436048] |
| 11. Romi, Hila H and 10 more authors.. (2012) Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.. American journal of human genetics, (4): [PMID:22521417] |
| 12. Busby, Robert W RW and 10 more authors.. (2013) Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.. The Journal of pharmacology and experimental therapeutics, [PMID:23090647] |
| 13. Arshad, Najla N, Ballal, Suhas S and Visweswariah, Sandhya S SS.. (2013) Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36.. The Journal of biological chemistry, (8): [PMID:23269669] |
| 14. Mathur D, Root AR, Bugaj-Gaweda B, Bisulco S, Tan X, Fang W, Kearney JC, Lucas J, Guffroy M, Golas J et al.. (2020) A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers.. Clin Cancer Res, 26 (9): (2188-2202). [PMID:31996389] |